The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Honoraria - Amgen; Astellas Pharma; Janssen; Merck; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; CureVac; ESSA; Janssen; Orion; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Amgen
 
Honoraria - Amgen; Astellas Pharma; Bayer; Clovis Oncology; Gilead Sciences; Janssen; Lilly; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Clovis Oncology; Gilead Sciences; Janssen; Lilly; Novartis; Pfizer
Research Funding - Amgen (Inst); Bayer (Inst); Gilead Sciences (Inst); Janssen (Inst); Lilly (Inst)
Phase II study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD): Preliminary results of GALAHAD.
 
Matthew Raymond Smith
No Relationships to Disclose
 
Shahneen Kaur Sandhu
Honoraria - Amgen; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
William Kevin Kelly
Honoraria - Sanofi
Consulting or Advisory Role - Sanofi
Research Funding - Janssen Oncology (Inst); Novartis (Inst); Sanofi (Inst)
Other Relationship - Sanofi
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Stock and Other Ownership Interests - Asterias Biotherapeutics
Consulting or Advisory Role - Ambry Genetics/Konica Minolta; Janssen; Janssen Research & Development; OncLive Insights; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group
Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Asterias Biotherapeutics; OncLive Insights; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group
 
Eleni Efstathiou
Honoraria - Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Innocrin Pharma; Janssen-Cilag; MSD; Sanofi; Takeda; Tolmar
Speakers' Bureau - Janssen-Cilag
Research Funding - Astellas Pharma; Janssen-Cilag; Sanofi
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; CellMax Life; Exelixis; Foundation Medicine; Genentech/Roche; Janssen; Merck; Nektar; Pfizer; Turnstone Bio
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Incyte (Inst); Janssen Biotech (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Polaris (Inst); TRACON Pharma (Inst)
 
Evan Y. Yu
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Churchill Pharmaceuticals; EMD Serono; Incyte; Janssen; Merck; QED Therapeutics; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen (Inst)
 
Daniel J. George
Honoraria - Bayer; Exelixis; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech; Innocrin Pharma; Janssen; Merck Sharp & Dohme; Myovant Sciences; Pfizer; Sanofi
Speakers' Bureau - Bayer; Exelixis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Merck; Pfizer; Sanofi
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
 
Jason Summa
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Nishi Kothari
No Relationships to Disclose
 
Xin Zhao
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Byron M. Espina
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Deborah S. Ricci
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jason S. Simon
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson
 
Namphuong Tran
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Karim Fizazi
No Relationships to Disclose